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CHARACTERISTICS OF CHILDREN ENROLLED IN MEDICAID USING 
RESPIRATORY EQUIPMENT AND SUPPLIES 
DIPIKA GAUR 
ABSTRACT 
Background: Emerging evidence suggests that the population of children assisted with 
respiratory medical equipment and supplies (RMES) is increasing in size and is having a 
substantial impact on families, providers, and the health system.		Little is known on a 
population level about children who use RMES to compensate for a deficit in the ability 
to breathe.	This study addressed these gaps by assessing (1) the characteristics of children 
in Medicaid using RMES and (2) how the use of RMES influences healthcare utilization 
and spending across the care continuum.  
Methods: A retrospective cohort analysis of 11,306 children using and 21,192 children 
not using RMES [propensity matched by age and complex chronic conditions (CCC)] 
who were age 0-to-21 years and continuously enrolled in Medicaid in 2013 from 10 states 
in the Truven Health Medicaid MarketScan Database.  RMES use at home (not counting 
acute use in a clinic, emergency department, or hospital) was identified with Healthcare 
Common Procedure Coding System (HCPCS), billed by medical supply companies, and 
International Classification of Diseases (ICD9) codes, billed by clinicians and hospitals. 
RMES included oxygen, suctioning, apnea monitor, CPAP/BiPAP, tracheostomy, 
ventilator, cough assist, and vest. We regressed RMES use on total annual per 
member per year (PMPY) Medicaid payments, adjusting for enrollment reason, gender, 
age, race/ethnicity, and number of chronic conditions. 
		 vii 
Results: Of children using RMES at home, 5% were identified with ICD9 only, 80% with 
HCPCS only, and 15% with ICD9 and HCPCS. Most (87%) children using RMES had a 
chronic condition (of any complexity); 71% had a complex chronic condition. 
Neuromuscular (32%) was the most common CCC. RMES usage among children 
included oxygen (47%), suctioning (28%), apnea monitor (23%), CPAP/BiPAP (22%), 
tracheostomy (17%), ventilator (8%), cough assist (5%), and vest (4%). PMPY payments 
in propensity-matched children using vs. not using RMES were $45,892 vs. $15,036, 
p<0.001. In adjusted analysis, payment increased significantly (p<.001) with use of 
CPAP/BiPAP (+$1,117), oxygen (+$3,525), cough assist (+$6,342), suctioning 
(+$8,569), tracheostomy (+$11,977), vest (+$11,999), apnea monitor (+$13,747), and 
ventilator (+$32,323). Of children using RMES, most payments were for hospitalization 
(57%), specialty care (24%), and medications (6%); <3% was for RMES or home 
nursing. 
Conclusion: RMES use can identify additional projected healthcare costs in children 
beyond consideration of chronic diagnoses. Because most of the cost of using RMES is 
due to inpatient and specialty care rather than the equipment itself, RMES may indicate – 
broadly - medical fragility and increased healthcare needs. Population health initiatives of 
children with medical complexity may benefit from consideration of RMES use in risk 
assessment for healthcare cost. 
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INTRODUCTION 
 
Medical Technology Assistance  
Individuals who are assisted by medical technology require the use of a medical 
device to compensate for the total loss or reduction of vital body function. There is 
significant variation in the patient populations who require medical technology assistance 
(MTA), as well as in the types of technologies utilized.1,2 (Figure 1) For example, 
children with diabetes mellitus type 1 who require regular administration of insulin to 
compensate for insufficient production by the body can utilize insulin pumps.3 Patients 
with acute or chronic renal insufficiency may require dialysis to compensate for lost 
kidney function. How long a patient has to remain on dialysis treatments is highly 
individualized and depends on the severity of his or her disease.4  	
 
Figure 1: Technologies Utilized By Patients with Various Medical Conditions 
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Medical Technology Assistance Among Children     
 Among individuals with MTA, children represent a growing, medically complex 
patient population with unique health care needs and various underlying conditions. 
While many different definitions have been proposed for children with MTA, there is no 
standardized terminology and definition in use for this population. This lack of 
standardized terminology is a barrier to locating, sharing, and aggregating data to 
improve patient care and outcomes. One well known and often cited definition5-7 comes 
from the United States Office of Technology Assessment (USOTA). In 1987, the 
USOTA defined the technology-dependent child as one who requires “a medical device 
to compensate for the loss of a vital body function and substantial and ongoing nursing 
care to avert death or further disability.”8 Notably, this long-standing definition does not 
specify the setting of care delivery, qualifications of the care-giver, or duration of 
medical device utilization. These aspects of care for children with MTA have remained 
individualized for each patient, depending on the severity of his or her condition and 
dynamics of the child’s social and home environments.      
 Although the USOTA refers to these children as technology-dependent children, 
other frequently used terms include: children with MTA, children with assistive 
technology, and technology-assisted children. In this paper, children who require the use 
of a medical device to compensate for the total loss or reduction of vital body function 
will be referred to as children with MTA. This terminology employs “person-first” 
language, emphasizing that a child’s medical condition is one part of his or her identity.9 
Unlike the definition from the USOTA, the one used in this paper does not specify 
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nursing care requirements, as there is significant variation in each child’s needs. 
Additionally, physicians who care for children with MTA have disagreed about how 
much emphasis to place on nursing care and whether to include nursing care in the 
definition of this patient population10.       
 Children with MTA include, but are not limited to, children who require one or 
more of the following: tracheostomy, respirator, ventilator, supplementary oxygen, 
suctioning, gastrostomy, jejunal or nasogastric feeding tubes, urostomy, urethral 
catheterization, central venous access, or dialysis1. As demonstrated by this range of 
technologies and procedures, patients with a variety of clinical diagnoses require 
technology assistance as part of their long-term care needs. (Table 1) 	
Table 1: List of Affected Organ Systems and Related Clinical Diagnoses That May Require MTA1 
Organ System  Diagnoses 
Neurologic Congenital anomalies of the central nervous system; 
spastic quadriplegia; neuromuscular disorders; spinal 
cord injuries; seizure disorders; central nervous 
system infections; hypoxic and other 
encephalopathies 
Multisystem Inborn errors of metabolism; chromosomal 
anomalies; acquired immunodeficiency syndrome 
Cancer-hematologic Leukemia; solid organ malignancies; thalassemia; 
sickle cell anemia; hemophilia 
Cardio-respiratory Bronchopulmonary dysplasia; asthma; chronic lung 
disorders; congenital heart disease 
Gastrointestinal-metabolic Inflammatory bowel disease; gastroesophageal 
reflux; dumping syndrome; malabsorption; 
necrotizing enterocolitis; congenital anomalies of the 
gastrointestinal tract 
Renal-genitourinary Chronic renal failure; congenital genitourinary 
anomalies; glomerulonephritis 
Musculoskeletal Arthritis; osteomyelitis; osteogenesis imperfecta; 
Ehlers-Danlos syndrome 
Immunologic Agammaglobulinemia; hypogammaglobulinemia  
	4 
 Advancements in medical technology have reduced patient mortality and 
contributed significantly to the growing population size of children with MTA.11 
Technological improvements have also allowed many of these children, who previously 
required continuous inpatient care, to successfully transition from hospitals and long-term 
care facilities to home-based care.12  There are numerous emotional and social benefits to 
living at home for patients and their families. In addition, home-based care may decrease 
healthcare costs and mitigate other financial stressors associated with lengthy, complex 
hospitalizations. Previous studies show that children with MTA have long hospital stays, 
multiple providers involved in their care, high inpatient resource utilization, and 
insufficient care coordination to meet their complex health needs.11,13 Hospital discharge 
of these complex patients is often prolonged because of non-medical reasons14-16, 
including delayed public funding approval and availability of home nursing care.  As the 
number of children with MTA who transition from hospital to home-based care increases, 
research on the impact of changes in healthcare delivery on resource utilization and costs 
is imperative. 
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Figure 2: Factors Delaying Discharge from ICU with Respiratory Technology 16 	
Children with Respiratory Technology Assistance   
Included in the population of children with MTA are patients with respiratory 
system morbidities. Children with respiratory TA are those who require respiratory 
medical equipment and supplies (RMES) to maintain optimal pulmonary function. The 
respiratory system is comprised of multiple organs and structures that can be 
anatomically divided into two portions – the upper and lower respiratory tracts. The 
upper respiratory tract includes the nose, pharynx, and larynx. The lower respiratory tract 
includes the trachea, left and right bronchi, bronchioles, and lungs. (Figure 2) Within the 
lungs, the smallest units of respiration are the alveoli – tiny, sac-like structures that serve 
as the site of gaseous exchange between the lungs and blood. Collectively, millions of 
alveoli facilitate the transport of oxygen from air into the blood and removal of carbon 
dioxide from blood into the air. (Figure 3) This gaseous exchange of oxygen and carbon 
dioxide is the main function of the respiratory system.  
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RMES are utilized by patients when respiratory function is compromised due to a 
variety of underlying conditions and causes. Impairment of respiratory function can be 
intermittent or chronic, and the technologies described in the next subsection are utilized 
by patients to supplement or take over the body’s respiratory efforts.  	
Respiratory Medical Equipment and Supplies 
Oxygen  
Patients with a variety of medical conditions, such as chronic obstructive pulmonary 
disease (COPD), bronchopulmonary dysplasia, or heart failure, may require oxygen 
therapy, which is also known as supplemental oxygen. Oxygen therapy involves giving 
oxygen to an individual via face mask or nasal tubes to increase blood oxygen levels and 
counter the hazardous effects of low blood oxygen concentration. Oxygen therapy can be 
administered over short or long periods of time in multiple healthcare settings (i.e. 
hospital, rehabilitation facility, home, school, etc.) Portable tanks and oxygen 
concentrators allow patients to receive oxygen therapy while moving around. In portable 
tanks, Oxygen is stored as a gas or liquid form and can be re-filled. Oxygen concentrators 
are devices which concentrate oxygen from a gaseous supply – typically ambient air– for 
immediate use by the patient. 
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Figure 3: Components of a Portable Oxygen Concentrator. Source: The Oxygen Concentrator Store. Downloaded 
from: http://www.oxygenconcentratorstore.com 
 
Noninvasive positive pressure ventilation 
Noninvasive positive pressure ventilation (NPPV) refers to the administration of 
positive pressure ventilatory support without using an invasive artificial airway (i.e. a 
tracheostomy tube). NPPV is indicated for multiple conditions, including obstructive 
sleep apnea, chronic neuromuscular disease, facial and/or pharyngeal malformations and 
dysfunctions, and respiratory disease.17 Over the past 20 years, NPPV has become an 
integral management tool for acute and chronic respiratory failure in hospital and home-
based patient care.18 In NPPV, air pressure is administered into an individual’s airways, 
through a face mask, nasal mask, or nasal plugs, to prevent respiratory distress (i.e. 
airway collapse) and improve breathing. NPPV can be continuous (CPAP), bi-level 
(BiPAP), or automatically adjusting (APAP). CPAP machines constantly administer air at 
a single level of air pressure. Unlike CPAP, BiPAP machines cyclically deliver air at two 
distinct pressures – a higher pressure during inhalation and a lower pressure during 
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exhalation. Like CPAP, APAP provides continuous provision of air pressure into the 
airways. However, APAP machines use built-in technology to recognize changes in an 
individual’s breathing and adjust the air pressure being administered to an appropriate 
level.  
 
Figure 4: Administration of Noninvasive Positive Airway Pressure. Source: PruebasBMA. Downloaded from 
https://en.wikipedia.org/wiki/Positive_airway_pressure 
 
Cough Assist 
Respiratory problems that impair breathing also impact an individual’s ability to 
cough. When an individual is unable to cough regularly, the lungs and airways retain 
excess secretions, increasing the risk of infection, inflammation, and eventually, 
respiratory failure. Cough assist devices help patients with loosening and clearing 
secretions by providing high frequency oscillatory vibrations while gradually applying a 
positive pressure to the airway, then rapidly shifting to a negative pressure. The 
oscillatory vibrations assist in loosening and mobilizing the secretions and the rapid shift 
in pressure produces a high expiratory flow rate from the lungs, promoting the clearance 
of secretions. A cough assist device can be used with either a facemask, mouthpiece, or 
with an adapter to a patient’s endotracheal or tracheostomy tube. Cough assist devices 
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can be used by adult and pediatric patients for secretion clearance and/or inability to 
cough in various healthcare settings (i.e. hospitals, institutional environments, or home). 
 
Tracheostomy 
A tracheotomy is a surgical procedure in which a surgeon makes an incision through 
the skin of the neck into the trachea and creates an opening to accommodate a 
tracheostomy tube. (Figure 4) Once the tracheostomy tube is inserted into this opening, it 
serves as a passageway for patients to breathe and for removal of secretions. A patient 
with a tracheostomy tube breathes through the tube, instead of using his or her nose and 
mouth. Although the terms are often, incorrectly used interchangeably17,19, tracheotomy 
refers to the surgical procedure and tracheostomy refers to the hole-like opening.  
 
Figure 5: Tracheostomy. Source: Mayo Clinic. Downloaded from: http://www.mayoclinic.org/tests-
procedures/tracheostomy/home/ 
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Tracheostomy tubes are indicated for children who cannot control their breathing, 
patients with upper airway obstruction, and patients supported by long-term mechanical 
ventilation. While the specifics of tracheostomy care are individualized to each patient’s 
needs (i.e. whether the patient uses a cuffed tracheostomy tube), standards of care in 
hospitals and other healthcare facilities include the following: 24-hour access to a 
provider trained in addressing tracheostomy complications, routine visits from respiratory 
therapists, attention to humidification and suctioning (removal of secretions) needs, and 
ready availability of replacement tracheostomy tubes of the appropriate size.17,20 Once a 
child with a tracheostomy tube is deemed medically stable by his or her physician, the 
patient can transition from hospital to home-based care, given the following: completion 
of caregiver education, establishment of home nursing and respite care plan, availability 
of durable medical equipment and supplies, and lack of catastrophic financial concerns. 
Whether in an institutional or home environment, children who utilize tracheostomy 
tubes require regular support from trained caregivers.20   
 
Suction  
A tracheostomy tube bypasses the upper airways, which warm, moisten, and clean the 
air we breathe. In the absence of these protective measures, the air that travels through 
the tracheostomy tube is cooler, drier, and less clean. In response, the airways produce 
more mucus. Suctioning clears mucus from the tracheostomy tube, promoting adequate 
breathing and preventing contamination of the tube and potential infection. Notably, 
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suctioning should be conducted as recommended by the patient’s health care team, but 
suctioning too frequently can lead to increased production of mucus by the body.  
 
Figure 6: Suctioning a Tracheostomy. Source: Kids Health. Downloaded from https://kidshealth.org/ 	
 
High Frequency Chest Wall Oscillation (HFCWO) Assistance Vests  
HFCWO is a routine part of care for many patients who require assistance with 
airway clearance. HFCWO technology consists of an inflatable vest and air pulse 
generator that is connected to the vest by hoses. (Figure 7) The inflatable vest is worn by 
the patient, and the air pulse generator mimics manual chest physical therapy by vibrating 
at variable frequencies and intensities, as set by the patient’s caregiver. The generator 
sends air into the vest through the hoses, causing the vest to inflate and deflate quickly. 
The rapid, cyclic inflation and deflation have a similar effect as that of manual clapping 
on a patient’s chest. The vibrations dislodge mucus from the lining of the airways and 
facilitate movement of mucus up from smaller airways into larger airways. Treatment 
sessions with HFCWO vests commonly last 30 minutes and incorporate regular breaks to 
facilitate coughing and respiration, as needed.21 HFCWO vests are widely used for 
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treatment of various respiratory diseases in the United States, and are considered part of 
standard care procedures for treatment of cystic fibrosis.21,22  
 
Figure 7: Child Using HFCWO Vest. Source: Bronchiectasis Toolbox. Downloaded from 
http://bronchiectasis.com.au/ 	
Ventilator 
Mechanical ventilators assist patients with breathing by delivering gas to the 
airways through a set of tubes known as the patient circuit. Ventilators work by 
mimicking the breathing patterns of adults and children, and the machines are 
programmed to deliver gas at a specific number of breaths per minute, as set by a health 
professional or caregiver. In invasive ventilation, the circuit connects the ventilator to an 
endotracheal tube or a tracheostomy tube. In noninvasive ventilation, the circuit connects 
the ventilator to nasal prongs, a nasal mask, or a facial mask. Mechanical ventilators can 
be used by patients in a variety of healthcare settings. Some patients require mechanical 
ventilation for short periods of time (i.e. when recovering from an injury), while others 
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may require long-term ventilation support, depending on their diagnosis and treatment 
plan.  
 
Apnea Monitor  
Apnea monitors are devices that continuously measure an individual’s chest 
movements and heart rate for any pauses in breathing (apnea) or slowing of the heart rate 
below age-appropriate levels (bradycardia). These monitors are primarily used to detect 
the cessation of breathing in infants and adults who are at risk for respiratory failure and 
alert the individual’s caregiver to their worsening condition.  During prolonged pauses in 
respiration, the body’s oxygen concentration decreases, which can lead to irreversible 
brain damage or death. Children may require apnea monitoring in the hospital and/or 
home for a variety of reasons, including: prematurity, chronic lung disease, neurologic or 
metabolic disorders affecting respiratory control, presence of an anatomic abnormality or 
use of a tracheostomy that increases likelihood of airway compromise. While the specific 
components of an apnea monitor may vary by brand, they are generally composed of 
sensors that attach to the skin and obtain information on physiological parameters like 
heart rate. These sensors are connected to a monitor that analyzes this information and 
determines whether or not apnea is occurring. If apnea is detected, the monitor will sound 
an alarm to alert the child’s or adult’s caregiver.  
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SPECIFIC AIMS 
 
 The specific aims of this study are (1) to assess the prevalence of children 
enrolled in Medicaid using respiratory durable medical equipment (2) to assess how the 
use of respiratory medical equipment and supplies (RMES) influences healthcare 
utilization and spending across the care continuum.		 
 
METHODS 
Study Design and Setting 
  This is a retrospective cohort study of healthcare claims data contained in the 
Truven MarketScan Medicaid Multistate Database from 2012 to 2014. The Truven 
database contains information on inpatient admissions, inpatient services, outpatient 
services, prescription drug claims, long-term care, and other medical care from ten state 
contributors. The Truven database is de-identified and complies with the Health 
Insurance Portability and Accountability Act of 1996 (HIPAA). A review of this study by 
the Boston Children’s Hospital Institutional Review Board was waived, because the study 
did not collect, use, or transmit any individually identifiable data.  
 
Study Participants 
Study participants were children ages 0-18 who (1) used RMES in 2013 and (2) 
were continuously enrolled in Medicaid for 11 to 12 months before their first RMES 
healthcare claim (if child was age 11 months or older in January 2013), as well as 12 
months after the first claim (for all ages). Two methods were used to identify RMES 
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usage among children: (1) International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) diagnosis and procedure codes and (2) the Healthcare 
Common Procedure Coding System (HCPCS).  
 
Respiratory Medical Equipment and Supply ICD-9-CM Codes 
 ICD-9-CM codes correspond to specific diagnoses and procedures that are part of 
medical care provided to patients. These codes are utilized for diagnostic, billing, and 
reporting purposes by clinical professionals and healthcare administrators. For example, 
ICD-9-CM codes are regularly utilized by administrators to indicate diagnoses and 
procedures for a patient interaction when submitting reimbursement claims to payers, 
such as insurance companies. In this study, the ICD-9-CM code categories used to 
identify RMES usage among children include: tracheostomy, mechanical ventilation, 
suction, and oxygen. (Table 2)  	
Respiratory Medical Equipment and Supply HCPCS 	 The Centers for Medicare and Medicaid Services’ HCPCS is a set of codes that 
corresponds to specific items and procedures provided to patients as part of medical care, 
including non-physician services and equipment, like ambulance services and durable 
medical equipment. For example, companies that supply durable medical equipment to 
patients utilize HCPCS when sending billing claims to payers. In this study, HCPCS 
codes were categorized into the following groups to identify RMES usage among 
children: apnea monitor, cough assist, non-invasive positive pressure, oxygen, suction, 
tracheostomy, mechanical ventilator, and vest. (Table 2) 
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Table 2: ICD9 and HCPCS Codes Utilized For Specific RMES 
System Code Description 
Tracheostomy 
ICD9 31.2 Permanent tracheostomy 
31.21 Mediastinal tracheostomy 
31.29 Other permanent tracheostomy 
31.41 Tracheoscopy through artificial stoma 
31.74 Revision of tracheostomy 
33.21 Bronchoscopy through artificial stoma 
96.55 Tracheostomy toilette 
97.23 Replacement of tracheostomy tube 
519.xx Tracheostomy complications 
V44.0 Artificial opening status - tracheostomy 
V55.0 Attention to artificial openings – tracheostomy 
HCPCS A7526 Tracheostomy tube collar/holder, each 
A7520 Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), 
silicone or equal 
A7525 Tracheostomy mask 
A4629 Tracheostomy care kit for established tracheostomy 
A7521 Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone 
or equal 
L8501 Tracheostomy speaking valve 
A7507 Filter holder and integrated filter, tracheostomy heat and moisture exchange 
system 
S8189 Tracheostomy supply, not otherwise classified 
A4623 Tracheostomy, inner cannula 
A7509 Filter holder, housing, and adhesive, tracheostomy heat and moisture 
exchange system 
A4625 Tracheostomy care kit for new tracheostomy 
A7527 Tracheostomy/laryngectomy tube plug/stop 
A7504 Filter for use in a tracheostomy heat and moisture exchange system 
A4626 Tracheostomy cleaning brush 
A7503 Filter holder or filter cap, reusable, tracheostomy heat and moisture 
exchange system 
A7522 Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and 
reusable) 
A7523 Tracheostomy shower protector 
Oxygen 
ICD9 V46.2 Dependence on supplemental oxygen 
HCPCS E1390 Oxygen concentrator, single delivery port, capable of delivering 85 percent 
or greater oxygen concentration at the prescribed flow rate 
 E0431 Portable gaseous oxygen system, rental; includes portable container, 
regulator, flowmeter, humidifier, cannula or mask, and tubing  
 E0445 Oximeter device for measuring blood oxygen levels non-invasively  
 A4606 Oxygen probe for use with oximeter device, replacement 
 E0565 Compressor, air power source for equipment which is not self-contained or 
cylinder driven  
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 E0424 Stationary compressed gaseous oxygen system, rental; includes container, 
contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and 
tubing 
 K0738 Portable gaseous oxygen system, rental; home compressor used to fill 
portable oxygen cylinders; includes portable containers, regulator, 
flowmeter, humidifier, cannula or mask, and tubing 
 E0441 Oxygen contents, gaseous (for use with owned gaseous stationary systems 
or when both a stationary and portable gaseous system are owned), 1 
month’s supply = 1 unit 
 E0439 Stationary liquid oxygen system, rental; includes container, contents, 
regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing  
 E0550 Humidifier, durable for extensive supplemental humidification during IPPB 
treatments or oxygen delivery  
 E0434 Portable liquid oxygen system, rental; includes portable container, supply 
reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or 
mask, and tubing  
 E0443 Portable oxygen contents, gaseous (for use only with portable gaseous 
systems when no stationary gas or liquid system is used), 1 month’s supply 
= 1 unit  
 E1392 Portable oxygen concentrator, rental 
 E1353 Regulator 
 E0560 Humidifier, durable for supplemental humidification during IPPB treatment 
or oxygen delivery  
 E0442 Oxygen contents, liquid (for use with owned liquid stationary systems or 
when both a stationary and portable liquid system are owned), 1 month’s 
supply = 1 unit  
 E0430 Portable gaseous oxygen system, purchase; includes regulator, flowmeter, 
humidifier, cannula or mas, and tubing  
 E0444 Portable oxygen contents, liquid (for use only with portable liquid systems 
when no stationary gas or liquid system is used), 1 month’s supply = 1 unit  
    Ventilator 
ICD9 34.85 Implantation of diaphragmatic pacemaker 
 V46.1 Dependence on respirator (ventilator) 
HCPCS A4483 Moisture exchanger, disposable, for use with invasive mechanical ventilation  
 E0463 Pressure support ventilator with volume control mode, may include pressure 
control mode, used with invasive interface (e.g. tracheostomy tube) 
 E0464 Pressure support ventilator with volume control mode, may include pressure 
control mode, used with non-invasive interface (e.g. mask) 
 E0450 Volume control ventilator, without pressure support mode, may include 
pressure control mode, used with invasive interface (e.g. tracheostomy tube) 
 A4611 Battery, heavy duty; replacement for patient owned ventilator 
 A4613 Battery charger; replacement for patient-owned ventilator  
 E0461 Volume control ventilator, without pressure support mode, may include 
pressure control mode, used with a non-invasive interface 
                                                Suction 
ICD 9 V46.0 Aspirator 
HCPCS A7002 Tubing, used with suction pump, each 
 A7000 Canister, disposable, used with suction pump, each 
 A4624 Tracheal suction catheter, any type other than closed system, each 
 E0600 Respiratory suction pump, home model, portable or stationary, electric 
 A4605 Tracheal suction catheter, closed system, each 
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 A7001 Canister, non-disposable, used with suction pump, each 
                                                Vest 
HCPCS E0483 High frequency chest wall oscillation air-pulse generator system, (includes 
hoses and vest), each 
 E0480 Percussor, electric or pneumatic, home model 
 E0481 Intrapulmonary percussive ventilation system and related accessories 
 A7025 High frequency chest wall oscillation system vest, replacement for use with 
patient owned equipment, each 
                                              Oral Airway 
HCPCS E0486 Oral device/appliance used to reduce upper airway collapsibility, adjustable 
or non-adjustable, custom fabricated, includes fitting and adjustment  
                                             CPAP/BiPAP 
HCPCS A7035 Headgear used with positive airway pressure device 
 A7038 Filter, disposable, used with positive airway pressure device 
 E0601 Continuous airway pressure (CPAP) device 
 A7037 Tubing used with positive airway pressure device 
 E0562 Humidifier, heated, used with positive airway pressure device 
 A7030 Full face mask used with positive airway pressure device, each 
 A7034 Nasal interface (mask or cannula type) used with positive airway pressure 
device, replacement, each 
 A7039 Filter, non-disposable, used with positive airway pressure device  
 A7046 Water chamber for humidifier, used with positive airway pressure device, 
replacement, each 
 A4604 Tubing with integrated heating element for use with positive airway 
pressure device 
 E0561 Humidifier, non-heated, used with positive airway pressure device 
 A7036 Chinstrap used with positive airway pressure device 
 A7027 Combination oral/nasal mask, used with continuous positive airway pressure 
device, each 
 A7044 Oral interface used with positive airway pressure device, each 
                                                Cough Assist 
HCPCS E0482 Cough stimulating device, alternating positive and negative airway pressure 
 E0471 Respiratory assist device, bi-level pressure capability, with back-up rate 
feature, used with noninvasive interface, e.g., nasal or facial mask 
(intermittent assist device with continuous positive airway pressure device) 
 E0470 Respiratory assist device, bi-level pressure capability, without back-up rate 
feature, used with noninvasive interface, e.g., nasal or facial mask 
(intermittent assist device with continuous positive airway pressure device) 
 E0484 Oscillatory positive expiratory pressure device, non-electric, any type, each 
 E0472 Respiratory assist device, bi-level pressure capability, with backup rate 
feature, used with invasive interface, e.g., tracheostomy tube (intermittent 
assist device with continuous positive airway pressure device) 
                                            Apnea Monitor 
HCPCS E0619 Apnea monitor, with recording feature 
 A4556 Electrodes, (e.g. apnea monitor), per pair 
 A4557 Lead wires, (e.g. apnea monitor), per pair 
 E0618 Apnea monitor, without recording feature 
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Main Outcome Measures  
The main outcomes were total healthcare expenditure and utilization of services 
over a 12-month period. In order to confirm inclusion of a complete 12-month period of 
RMES usage, outcomes were evaluated during the 12 months following either (1) the 
first RMES claim in 2013 for children without a claim in the preceding 12 months, 
including in 2012; or (2) January, 1, 2013 for children with a RMES claim in 2012. 
Outcomes were assessed across all services and by individual health services. These 
health services include dental, durable medical equipment, emergency department, home 
health, inpatient, primary care, specialty care, and therapy (i.e. physical, occupational, 
and other outpatient therapies).  Expenditure was described for each health service as the 
gross payment. Utilization was reported as the proportion of patients using each health 
service and the frequency of claims for the respective service. 
 
Demographic and Clinical Characteristics of the Children  
 The demographic characteristics of interest were age, gender, race/ethnicity, basis 
of eligibility for Medicaid, and provider payment systems (i.e. fee-for-service and/or 
managed care plans). Each child’s age, gender, and race/ethnicity were recorded at the 
time of their first RMES claim in 2013. Clinical characteristics of interest were the 
number and type of chronic conditions, the number and identity of body systems affected, 
and medical technology assistance. Data for these clinical characteristics were measured 
for all healthcare encounters up to 12 months before and after the date of each child’s 
first RMES claim in 2013.  
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The Agency for Healthcare Research and Quality’s Chronic Condition Indicator 
(CCI) system was utilized to identify the number and type of chronic conditions. The CCI 
system classifies the approximately 14,000 current ICD-9-CM diagnosis codes into 
chronic and non-chronic conditions. CCI also classifies ICD-9-CM codes into one of 18 
body systems categories, providing further information on the number and identity of 
body systems that are affected by a chronic condition. A chronic condition is defined by 
the CCI as a condition that lasts 12 months or longer and fulfills one or both of the 
following criteria: (1) limits self-care, independent living, and social interactions; and/or 
(2) requires ongoing intervention with medical products, services, and special equipment. 
In this study, hospitalized children with a chronic condition were further categorized for 
presence of a complex chronic condition (CCC), according to an ICD-9-CM diagnosis 
classification system. A CCC refers to any medical condition that can be reasonably 
expected to last at least 12 months (unless death intervenes) and to involve either several 
different organ systems or 1 system severely enough to require specialty pediatric care 
and probably some period of hospitalization in a tertiary care center.23,24 Hospitalized 
children assisted by medical technologies were identified by ICD-9-CM codes for the 
utilization of a medical device to manage and treat a chronic illness or to maintain basic 
body functions necessary for sustaining life.  
 
Statistical Analysis  
Children who did use and did not use RMES were propensity matched by age and 
CCC. In bivariable analysis, we compared healthcare spending across the children’s 
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categorization of use of respiratory equipment and supplies using Wilcoxon Rank Sum 
tests.25  To assess these relationships in multivariable analysis, we derived a linear 
regression model - with total healthcare spending as the outcome - that included fixed 
effects for the children’s demographic and clinical characteristics.  We also derived a 
logistic regression model – with hospitalization as the outcome – using the same fixed 
effects.  All statistical analyses were performed using SAS v.9.4 (SAS Institute, Cary, 
NC), and the threshold for statistical significance was set at p<0.05.  
 
Limitations 
The Truven database contains a variety of outpatient health care encounters 
aggregated into an “other” category; most of the encounters in this category appear to be 
for specialty visits. The generalizability of the Truven database remains unknown, given 
Truven’s inability to disclose the states in their database and the absence of a nationally 
representative, validated database of children with Medicaid.  
	
Figure 8: Truven MarketScan Research Databases. Source: Truven Health Analytics, “Health Research Data For 
The Real World: MarketScan Databases” 
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RESULTS 
 
 Of all children who utilized RMES at home in 2013, 4.7% were identified using 
only ICD9 codes, 79.8% were identified using only HCPCS codes, and 15.5% were 
identified using both ICD9 and HCPCS codes. 
 70.5% of these children had a CCC, with neuromuscular (31.8%), cardiovascular 
(27.2%), and respiratory (25.2%) being the most common CCCs.  31.5% of children with 
CCC had six or more body systems affected by their condition. The most common RMES 
used were supplementary oxygen (47.2%), suctioning (27.9%), apnea monitors (22.4%), 
CPAP/BiPAP (21.9%), and tracheostomies (16.5%). Other RMES utilized include 
ventilators (7.8%), cough assist (4.8%), and HFCWO assistance vests (4.1%). 
 Data presented in Tables 3-7 separate study participants into three categories: (1) 
all children who utilized RMES in 2013 (2) children who did not utilize RMES in 2012, 
but did utilize RMES in 2013 and (2) children who utilized RMES in 2012 and 2013. 
These categories are respectively referred to as overall, incident, and prevalent in Tables 
3-7. Results shared in this section and the discussion focuses on all children who utilized 
RMES in 2013.  
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Table 3: Demographic and Clinical Characteristics of Children  Assisted with RMES 
    Overall Cohort Type 
Incident 
  
Prevalent 
P 
# and % of 
Enrollees 
  12861 7877 (61.3) 4984 (38.8)   
  ICD9 Only 608 (4.7) 441 (5.6) 167 (3.4) <.001 
  HCPCS Only 10261 (79.8) 6953 (88.3) 3308 (66.4)   
  Both ICD9 and HCPCS 1992 (15.5) 483 (6.1) 1509 (30.3)   
Age: Median 
[IQR] 
0 3264 (25.4) 3264 (41.4)   <.001 
  1-4 2925 (22.7) 1522 (19.3) 1403 (28.2)   
  5-12 3610 (28.1) 1712 (21.7) 1898 (38.1)   
  13-17 1903 (14.8) 929 (11.8) 974 (19.5)   
  18+ 1159 (9) 450 (5.7) 709 (14.2)   
BOE Blind/Disabled Individual 5084 (39.5) 2111 (26.8) 2973 (59.7) <.001 
  Other 7777 (60.5) 5766 (73.2) 2011 (40.3)   
Race White 5732 (44.6) 3720 (47.2) 2012 (40.4) <.001 
  Black 2810 (21.8) 1870 (23.7) 940 (18.9)   
  Hispanic 928 (7.2) 694 (8.8) 234 (4.7)   
  Other 3391 (26.4) 1593 (20.2) 1798 (36.1)   
Gender Male 7115 (55.3) 4303 (54.6) 2812 (56.4) 0.046 
  Female 5746 (44.7) 3574 (45.4) 2172 (43.6)   
Managed Care Fee-for-service 5586 (43.4) 2698 (34.3) 2888 (57.9)   
  Capitated 7275 (56.6) 5179 (65.7) 2096 (42.1)   
CCCs v.2.0 Neuromuscular  4084 (31.8) 1471 (18.7) 2613 (52.4) <.001 
  CVD 3492 (27.2) 1845 (23.4) 1647 (33) <.001 
  Respiratory  3246 (25.2) 1187 (15.1) 2059 (41.3) <.001 
  Renal  828 (6.4) 326 (4.1) 502 (10.1) <.001 
  GI 3991 (31) 1564 (19.9) 2427 (48.7) <.001 
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  Hematology and 
immunodeficiency  
717 (5.6) 344 (4.4) 373 (7.5) <.001 
  Metabolic  1449 (11.3) 701 (8.9) 748 (15) <.001 
  Congenital or genetic defect  3001 (23.3) 1096 (13.9) 1905 (38.2) <.001 
  Malignancy 2463 (19.2) 1107 (14.1) 1356 (27.2) <.001 
  Neonatal 1992 (15.5) 1174 (14.9) 818 (16.4) 0.021 
  Tech Depend 4247 (33) 1520 (19.3) 2727 (54.7) <.001 
  Transplant 99 (0.8) 47 (0.6) 52 (1) 0.005 
  Any 9068 (70.5) 4833 (61.4) 4235 (85) <.001 
Technology 
Dependence 
(from CCCs 
v.2.0) 
Respiratory  1980 (15.4) 404 (5.1) 1576 (31.6)   
  GI 3801 (29.6) 1453 (18.4) 2348 (47.1)   
  CV 525 (4.1) 196 (2.5) 329 (6.6)   
  Neuromuscular  519 (4) 191 (2.4) 328 (6.6)   
  Other 4854 (37.7) 2506 (31.8) 2348 (47.1)   
  Renal  201 (1.6) 79 (1) 122 (2.4)   
N CCI Body 
Systems 
 0 981 (7.6) 890 (11.3) 91 (1.8) <.001 
  1 1685 (13.1) 1476 (18.7) 209 (4.2)   
  2 1672 (13) 1349 (17.1) 323 (6.5)   
  3 1600 (12.4) 1164 (14.8) 436 (8.7)   
  4 1478 (11.5) 894 (11.3) 584 (11.7)   
  5 1392 (10.8) 719 (9.1) 673 (13.5)   
  6+ 4053 (31.5) 1385 (17.6) 2668 (53.5)   
Oxygen   6076 (47.2) 2745 (34.8) 3331 (66.8) <.001 
Suction   3594 (27.9) 1454 (18.5) 2140 (42.9) <.001 
CPAP/BiPAP   2820 (21.9) 1363 (17.3) 1457 (29.2) <.001 
Cough Assist   621 (4.8) 159 (2) 462 (9.3) <.001 
Tracheostomy   2125 (16.5) 521 (6.6) 1604 (32.2) <.001 
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Vest   527 (4.1) 157 (2) 370 (7.4) <.001 
Ventilator   1007 (7.8) 127 (1.6) 880 (17.7) <.001 
Apnea Monitor   2876 (22.4) 2518 (32) 358 (7.2) <.001 
  
Children who use RMES at home may need both inpatient and outpatient 
healthcare services. Outpatient services include the following: emergency room, dental 
care, primary care, specialty care, laboratory testing, mental health services and substance 
abuse (MH/SA) care, obtaining medication, therapist care, durable medical equipment 
(DME) support, and home healthcare (HH) services.  
The most common healthcare services utilized by children who use RMES at 
home were the following outpatient services: medications (95.6%), primary care (92.5%), 
specialty care (87.9%), and laboratory testing (88%). Inpatient services were utilized by 
39.2% of children who use RMES at home. Notably, 57.2% of these children utilize other 
outpatient services, not included in the classifications used in this study.  
 
Table 4: Number and Percentage of Children Utilizing Each Healthcare Service 
Health Service Overall  Cohort Type 
Incident Prevalent p 
Inpatient 5042 (39.2) 3453 (43.8) 1589 (31.9) <.001 
Outpatient         
ED 7151 (55.6) 4695 (59.6) 2456 (49.3) <.001 
Dental 4699 (36.5) 2674 (33.9) 2025 (40.6) <.001 
PCP 11893 (92.5) 7396 (93.9) 4497 (90.2) <.001 
Spec/ Non-PCP Prof 11306 (87.9) 6714 (85.2) 4592 (92.1) <.001 
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Testing 11314 (88) 6981 (88.6) 4333 (86.9) 0.004 
Other 7358 (57.2) 4250 (54) 3108 (62.4) <.001 
MH/SA 5268 (41) 2726 (34.6) 2542 (51) <.001 
Medication 12292 (95.6) 7504 (95.3) 4788 (96.1) 0.031 
Therapy/Treatment 7637 (59.4) 4513 (57.3) 3124 (62.7) <.001 
DME 10326 (80.3) 5861 (74.4) 4465 (89.6) <.001 
HH 2621 (20.4) 1570 (19.9) 1051 (21.1) 0.113 
 
Total spending on healthcare services for children who used RMES at home in 
2013 was $737,198,077 USD. Of this amount, 57% ($421,855,396 USD) was spent on 
inpatient care. Outpatient services with the largest total expenditures by service were 
specialty care, medications, therapist care, MH/SA care, and HH services. Notably, the 
costs associated directly with DME were not one of the most expensive components of 
total healthcare spending for children who used RMES at home.  
 
Table 5: Total Spending in USD For Children Who Utilized Each Healthcare Service 
Health Service Overall  Cohort Type 
Incident  Prevalent  
Inpatient                  
421,855,396  
       
338,528,340  
      
83,327,056  
Outpatient       
ED                       
7,654,009  
            
4,997,546  
         
2,656,462  
Dental                       
1,923,259  
            
1,257,971  
            
665,288  
PCP                      
9,774,133  
            
7,107,950  
         
2,666,183  
Spec/ Non-PCP Prof                  
150,782,980  
         
39,995,821  
    
110,787,159  
Testing                       
9,326,776  
            
5,576,239  
         
3,750,537  
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Other                       
8,738,307  
            
3,522,875  
         
5,215,432  
MH/SA                    
22,220,800  
            
8,622,613  
      
13,598,187  
Drug/Inj                    
43,052,383  
         
16,064,529  
      
26,987,854  
Therapy/Treatment                    
25,301,272  
         
13,442,674  
      
11,858,598  
DME                    
16,041,801  
            
6,533,517  
         
9,508,284  
HH                    
20,526,961  
            
4,511,191  
      
16,015,769  
TOTAL                  
737,198,077  
       
450,161,268  
    
287,036,809  
 
The number of healthcare encounters a child with RMES support at home has 
with professionals from a specific healthcare service are indicative of how often children 
require each service, and which are more frequently used than others. Within a year, the 
healthcare services that required the highest number (presented as median value of set) of 
unique day encounters were the following: medications (20 days), MH/SA care (10 days), 
specialty care (8 days), primary care (6 days), DME support (6 days), and HH services (6 
days).  
 
Table 6: Median (IQR) Number of Unique Day Encounters for Children Who Utilized Each Health Service 
Health Service Overall Cohort Type 
Incident Prevalent p 
Inpatient 1 [1, 2] 1 [1, 2] 1 [1, 2] <.001 
Outpatient         
ED 2 [1, 3] 2 [1, 3] 2 [1, 3] <.001 
Dental 2 [1, 2] 2 [1, 3] 2 [1, 2] <.001 
PCP 6 [3, 11] 7 [4, 12] 5 [3, 9] <.001 
Spec/ Non-PCP Prof 8 [3, 30] 5 [2, 15] 19 [6, 79] <.001 
	28 
Testing 4 [2, 7] 4 [2, 7] 4 [2, 8] 0.219 
Other 3 [1, 7] 3 [1, 6] 4 [2, 8] <.001 
MH/SA 10 [2, 33] 7 [2, 26] 13 [3, 40] <.001 
Drug/Inj 20 [8, 51] 14 [7, 32] 39 [14, 80] <.001 
Therapy/Treatment 3 [1, 15] 2 [1, 9] 6 [2, 25] <.001 
DME 6 [2, 12] 4 [2, 10] 11 [4, 15] <.001 
HH 6 [2, 51] 4 [2, 10] 46 [6, 194] <.001 
 
Per member per year payments refer to the dollar amount paid to a provider 
(hospital or healthcare profession) each year for each person for whom the provider is 
responsible for healthcare delivery. This is the system by which managed care 
organizations pay providers, and in this paper the payer in question in Medicaid. Of the 
payments made for children who use RMES at home, most PMPY payments were for 
hospitalizations/inpatient care (57%), specialty care (24%), and medications (6%). Less 
than 3% of payments were for RMES or home nursing (indicated by DME and HH).  
 
Table 7: Total Annual PMPY Medicaid Payments For Children Who Utilized Each Healthcare Service 
Health Service Overall Cohort Type 
Incident Prevalent 
Inpatient 2733 3581 1393 
Outpatient       
ED 50 53 44 
Dental 12 13 11 
PCP 63 75 45 
Spec/ Non-PCP Prof 977 423 1852 
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Testing 60 59 63 
Other 57 37 87 
MH/SA 144 91 227 
Drug/Inj 279 170 451 
Therapy/Treatment 164 142 198 
DME 104 69 159 
HH 133 48 268 
TOTAL 4777 4762 4799 
 
PMPY payments in propensity-matched children using vs. not using RMES were 
$45,892 vs. $15,036 (p < 0.001). In adjusted analysis of PMPY payments, there were 
significant (p < 0.001) increases in payment by use of CPAP/BiPAP (+$1,117), oxygen 
(+$3,525), cough assist (+$6,342), suctioning (+$8,569), tracheostomy (+$11,977), vest 
(+$11,999), apnea monitor (+$13,747), and ventilator (+$32,323). In Table 8, the 
estimate values presented are increases in payment for use of the specific RMES, 
compared to no use. 
Table 8: Regression Analysis of Exposure to RMES and Total Cost 
RMES (used vs. not used) Estimate t Value Pr > |t| Alpha Lower 
Limit 
Upper 
Limit 
Oxygen          
3,525  
19.38 <.0001 0.05 3168.56 3881.69 
Suction          
8,569  
20.38 <.0001 0.05 7744.96 9393.66 
CPAP BiPAP          
1,117  
5.42 <.0001 0.05 713.32 1521.29 
Cough Assist          
6,342  
4.65 <.0001 0.05 3667.64 9015.63 
Tracheostomy  11,977  7.96 <.0001 0.05 9028.74 14925 
Vest   11,999  7.41 <.0001 0.05 8824.49 15174 
Ventilator   32,323  8.68 <.0001 0.05 25026 39620 
Apnea Monitor   13,747  25.9 <.0001 0.05 12707 14788 
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Table 9: Propensity Match of Children Who Use and Do Not Use RMES By Age and CCC. Cases include children 
who used RMES, and controls include children who did not use RMES. Variables used in the propensity score: BOE, 
CCC, CCI. Weights: Propensity Score (20%), Age (20%), Resp CCC (20%), Tech Dependency (20%). 11,306 cases 
matched to at least 1 control: 1,420 (12.6%) matched to 1 control, 9,886 (87.4%) matched to 2 controls.  
Variable    Overall Control Case p Standardized 
Difference 
Age group 0 8 (0) 4 (0) 4 (0.1) 0.052 0.04 
   1-4 6693 (30.1) 4464 
(30.8) 
2229 (28.9)   -0.04 
   5-12 8304 (37.4) 5373 
(37.1) 
2931 (38)   -0.85 
   13-17 4575 (20.6) 2963 
(20.4) 
1612 (20.9)   0.01 
   18+ 2623 (11.8) 1689 
(11.7) 
934 (12.1)   0.01 
BOE  
Blind/Disabled 
Individual 
8478 (38.2) 5463 
(37.7) 
3015 (39.1) 0.039 0.03 
  Other 13725 
(61.8) 
9030 
(62.3) 
4695 (60.9)   -0.03 
Neuromusc ccc   6539 (29.5) 4176 
(28.8) 
2363 (30.6) 0.004 0.04 
CVD ccc   3814 (17.2) 2401 
(16.6) 
1413 (18.3) 0.001 0.04 
Respiratory ccc   2198 (9.9) 1230 (8.5) 968 (12.6) 0.000 0.13 
Renal ccc   1119 (5) 705 (4.9) 414 (5.4) 0.101 0.02 
GI ccc   5398 (24.3) 3365 
(23.2) 
2033 (26.4) 0.000 0.07 
hemato/ Immuno 
ccc 
  1241 (5.6) 805 (5.6) 436 (5.7) 0.756 0.00 
Metabolic ccc   2432 (11) 1582 
(10.9) 
850 (11) 0.804 -0.46 
Congenital/genetic 
ccc 
  4391 (19.8) 2730 
(18.8) 
1661 (21.5) 0.000 0.07 
Malignancy ccc   2846 (12.8) 1758 
(12.1) 
1088 (14.1) 0.000 0.06 
Neonatal ccc   1095 (4.9) 646 (4.5) 449 (5.8) 0.000 0.06 
Tech dependent ccc   4564 (20.6) 2691 
(18.6) 
1873 (24.3) 0.000 0.14 
Transplant ccc   178 (0.8) 109 (0.8) 69 (0.9) 0.256 0.01 
Any ccc   13941 
(62.8) 
8976 
(61.9) 
4965 (64.4) 0.000 0.05 
CCC Body Systems 0 1444 (6.5) 960 (6.6) 484 (6.3) 0.002 -0.01 
  1 2773 (12.5) 1837 
(12.7) 
936 (12.1)   -0.02 
  2 2790 (12.6) 1814 
(12.5) 
976 (12.7)   0.01 
  3 3038 (13.7) 1983 
(13.7) 
1055 (13.7)   0.00 
  4 3120 (14.1) 2060 
(14.2) 
1060 (13.7)   -0.01 
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  5 3030 (13.6) 2045 
(14.1) 
985 (12.8)   -0.04 
  6+ 6008 (27.1) 3794 
(26.2) 
2214 (28.7)   0.06 
 
 
 
DISCUSSION 
 
 This study shows that utilization of RMES by children can identify additional 
projected healthcare costs, beyond consideration of chronic diagnoses. Understanding 
how RMES use impacts spending on services such as inpatient and outpatient care 
initiates a broader conversation about which aspects of service delivery for these patients 
– equipment and supplies, medications, hospitalizations, etc. – have higher associated 
costs and the development of guidelines to reduce costs and optimize health.     
 The attributes of children who use RMES at home show the increased complexity 
of care required for these patients prior to initial discharge from the hospital and as part 
of routine post-discharge care. Patients with multiple CCCs and MTA may need 
communication, proactive care planning, follow-up appointments with multiple 
outpatient specialty providers, equipment specialists, and home nursing at and after 
discharge.17,26 The success of these strategies to reduce hospitalizations in children who 
use RMES at home is at risk if outpatient providers and the health system are ill-equipped 
or unprepared to meet the health care needs of this highly vulnerable population.26 
 Neuromuscular CCCs were the most prevalent disease group among children who 
use RMES at home. Children with neuromuscular conditions are at high risk for 
uncoordinated care, unmet healthcare needs, and overuse of outpatient services. These 
individuals are especially vulnerable to healthcare service issues when attempting to 
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transfer from pediatric to adult care.27 Efforts to streamline and improve care 
coordination, follow-up of healthcare needs may improve health outcomes in children 
with neuromuscular conditions and decrease resource utilization and spending. Further 
investigation is needed to determine how to truly decrease spending and improve the 
health of this patient population.  
Because most of the cost of using RMES is due to inpatient and specialty care 
rather than the equipment itself, RMES may indicate – broadly - medical fragility and 
increased healthcare needs. Results from this study show that the highest costs associated 
with RMES use are due to hospitalizations, specialty care, and medications. Efforts to 
reduce healthcare spending and resource utilization may be most effective if they address 
these aspects of care. For example, decreasing hospital readmissions among children with 
RMES may be an actionable, cost-saving step. Studies show that many readmissions 
among pediatric patients with complex conditions may be avoidable. Some patients are 
rehospitalized for a problem in the same organ system as their recent readmissions.26 
Prospectively identifying these patients and delivering effective readmission prevention 
service could potentially lead to a substantial reduction in expenditures on 
hospitalization.  
Results from this study also demonstrated that the type of MTA assistance 
required by children who use RMES impacts healthcare costs. PMPY payments were 
highest for apnea monitors, ventilators, and vests, compared to other types of RMES. 
Identifying which RMES are associated with higher costs is an initial step, and further 
investigation is needed to evaluate if and how to influence spending on these 
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technologies. One important area of research for future studies is assessing whether more 
spending on certain health care services (i.e. inpatient care, specialty care, or home 
nursing) for children with RMES leads to better quality of care and contains costs. 
Population health initiatives of children with medical complexity may benefit 
from consideration of RMES use in risk assessment for healthcare cost. Currently, health 
care reform initiatives are taking place to analyze shared accountability for patient health 
outcomes and healthcare resource utilization amongst community and hospital based 
clinician teams.28,29 Episode-of-care experiments with a bundled payment for inpatient 
surgical and outpatient post hospitalization care have been associated with improved 
patient outcomes and reduced costs.30 As demonstrated in this study, children who use 
RMES and are enrolled in Medicaid experience a variety of complex, multi-system 
medical conditions, and often depend on multiple RMES to maintain vital bodily 
function. Consideration of how current and potential future RMES use impacts a child’s 
well-being and healthcare costs is important for developing effective, sustainable health 
initiatives.  
There are some limitations in this study. Because the Truven MarketScan 
Databases do not disclose states in their database and there is no nationally representative 
database of children with Medicaid, the generalizability of data from this source remains 
unknown. Despite these limitations, this study suggests that efforts to reduce spending 
and resource utilization should not be focused on the costs of RMES themselves, but on 
costs related to inpatient and outpatient healthcare services for the population of children 
who use RMES at home. Further investigation in this area is needed, and may result in 
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critical insight on how to improve the health of these children in the hospital, home, and 
in their communities.   
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